Belite Bio, Inc (BLTE) Tops Q4 EPS by 5c
Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.
Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.